#South Korea #Seoul #AI Technology #AIMD Inc. #A-LRYNGO

AIMD Expands Global Reach with A-LRYNGO, the First AI-Powered Video Laryngoscope

AIMD Inc., a leader in emergency medical technology based in South Korea, has recently launched A-LRYNGO™, the world's first AI-driven video laryngoscope that features real-time automatic glottis recognition. This revolutionary device is designed to assist medical professionals during intubation—a critical procedure performed over 100 million times annually worldwide.

The Importance of Intubation

Intubation is a complex and critical procedure that, when performed correctly, can save lives. However, the success of this procedure heavily relies on the skill level of the healthcare provider performing it. A failed or delayed intubation can lead to severe complications such as hypoxia, cardiac arrest, and even death. Given these high stakes, there is a pressing need for advanced, intelligent technologies that can aid clinicians in such critical moments.

How A-LRYNGO Works

A-LRYNGO transforms the typical video laryngoscopy experience by utilizing an integrated AI system that recognizes the glottis automatically. This innovative feature provides visual guidance in real-time without the need for external servers or continual license payments for AI usage. The device is designed to assist not only seasoned professionals but also those with limited intubation experience, making it a valuable tool in emergency medical settings.

The portable A-LRYNGO device allows clinicians to set up in less than five seconds, making it incredibly efficient in emergency situations. Furthermore, it includes capabilities for wireless screen sharing, video recording, and image capture, making the device multifunctional and user-friendly.

Recognition and Validation

The core AI technology behind A-LRYNGO has been developed through a national R&D program supported by South Korea's Ministry of Science and ICT (MSIT). It has undergone rigorous peer-reviewed studies published in esteemed journals such as IEEE Access and Medicine. Recently, A-LRYNGO received dual recognition from the South Korean government, being designated as an 'Excellent R&D Innovative Product' and recognized as a 'Next-generation World-Class Product,' highlighting both its innovative nature and its commercial viability.

In South Korea, A-LRYNGO is already widely utilized by emergency services and ambulance organizations, demonstrating significant adoption in the crucial prehospital emergency care sector. Furthermore, the technology is gaining traction internationally; it is currently being evaluated at the Mayo Clinic in the United States, supported by a Korean government-backed demonstration program. Over 200 units have been implemented in public hospitals across Uzbekistan, while organizations in Vietnam and Laos have also adopted the technology through international health cooperation programs.

A Vision for the Future

Dr. Tae Ho Lim, a professor of Emergency Medicine at Hanyang University and co-CEO of AIMD, states, "The future of airway management will go beyond simple visualization to a more intelligent guidance system during critical procedures. Our vision is to establish AI-guided intubation as the new global standard in airway management, making advanced emergency care accessible worldwide."

On September 18, AIMD showcased A-LRYNGO at the KOICA AI Partners’ Fair during the 19th Seoul ODA International Conference, and the next exhibition will be at the MEDICA 2026 in Düsseldorf, Germany, scheduled for next November.

About AIMD Inc.

AIMD Inc. emerged from the research environment of Hanyang University in Seoul and specializes in developing AI-driven medical technologies designed to provide real-time assistance during urgent and critical care procedures. For press and business inquiries, please contact Dr. JungChi Seo, co-CEO of AIMD Inc. at [email protected] or visit their website at aimdinc.com.